Simplifying Global Compliance
FDAnews Drug Daily Bulletin
GSK Completes Trials for Combination Lung Drug
Aug. 27, 2012
GlaxoSmithKline has completed final stage testing of its experimental once-daily lung disease drug LAMA/LABA and will press ahead with plans to file for approval of the medicine in global markets from the end of 2012.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing